Skip to content
OpenHORIZON-HLTH-2027-01-ENVHLTH-02HaDEAOne-off

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

Research on climate-related exposures within the human exposome.

Horizon Europe research action (RIA) that integrates climate-related exposures into the human exposome and maps how that exposome and the health effects change as a result of climate change.

Next deadline
91
days
17 February 2027
HORIZON-HLTH-2027-01-ENVHLTH-02
View all deadlines
Beta

This grant database is in beta

Until the official launch on 1 January 2027 we are making the final improvements. Our editors check every scheme, but details may still be incomplete or out of date. Check the official publication before you apply.

In brief

What is Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change?

Who
A consortium of at least three independent organisations from three different countries, of which at least one is from an EU Member State and the others from Member States or Associated Countries; research organisations, companies of any size, public authorities, foundations and associations can take part. Organisations from the United States can also receive EU funding; the Joint Research Centre may join after selection without funding or as an associated partner.
General Annex B (Entities eligible to participate; Entities eligible for funding; Consortium composition); Specific conditions, Eligibility conditions
What for
A research and innovation action to include climate-related exposures in the human exposome and to map how it changes as a result of climate change, so that the health risks of climate change are better understood and prevented.
Expected Outcome; Scope
What you get
A grant of 100% of eligible costs; the Commission considers an EU contribution of €10 to 11 million per project appropriate. The indicative budget for the topic is €45 million, expected to fund 4 projects.
Specific conditions (Expected EU contribution per project, Indicative budget); General Annex G, Funding rates
What you need to do
Submit a proposal in a single round via the Funding & Tenders Portal from 29 October 2026 until 17 February 2027 (17:00 Brussels time) at the latest, with application form Part A and Part B and, if the proposal includes clinical studies, the annex on clinical studies. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.
Planned opening; Deadline(s); Application and evaluation forms; General Annex F

Built from the details on this page, with nothing added by us.

Purpose & impact

Why does this scheme exist?

Better understand and prevent the health risks of climate change.

01
Better understanding of the exposome
Researchers, policymakers, healthcare providers and the public better understand the human exposome and the interplay between climate, environmental and socio-behavioural factors, supported by FAIR data linking these exposures to disease and health.
02
Knowledge of health effects
Researchers, public authorities, policymakers, social services and healthcare providers know more about the links between climate, social, lifestyle and environmental factors and the global burden of disease, so that they can apply the exposome approach.
03
Information for the public
The public has access to up-to-date information on the influence of global environmental exposures on health, making healthy, climate-resilient and nature-friendly behaviour easier.
Description

About the scheme

Compiled from passages of the scheme's official publication, with nothing added by us.

The exposome is the totality of exposures (and their interactions) experienced by an individual throughout their lifetime, including chemical, physical, biological, nutritional and psychosocial factors, from conception onwards. Many of these factors originate in the environment, including climate-related exposures such as extreme heat, heightened air pollution or drought. Climate change may amplify or interact synergistically with other better-established exposures, dynamically altering the human exposome and its health implications. Despite this, climate factors remain underrepresented in large-scale human exposome studies.

Am I eligible?

Conditions

Quoted verbatim from the scheme, with the article that sets each condition.

01
To be eligible for funding, applicants must be established in one of the following countries:
02
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.
03
Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.
04
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
05
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
06
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding as a beneficiary with zero funding, or as an associated partner.
All sizes
Micro< 10 FTE
Small< 50 FTE
Medium< 250 FTE
Large≥ 250 FTE
Themes
Onderzoek, ontwikkeling en innovatieGezondheid, zorg en welzijnEnergie, klimaat en verduurzaming
Project phase
ResearchDevelopment
Funding

What do you get?

100% of your eligible project costs.

Note on the maximum
No binding maximum; the Commission considers an EU contribution of €10 million to €11 million per project appropriate.
€45m · Indicative topic budget, expected to fund 4 projects.
Budget status
Not published by the source
The sources do not say how much budget is left (checked 18 November 2026).
No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).
Type
Direct grant (non-repayable)
Calendar

Deadlines & cycles

17
FEB
HORIZON-HLTH-2027-01-ENVHLTH-02 closes 17 February 2027
Open since 29 October 2026
Planned opening; Deadline(s)Active
Cycle: Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F). General Annex F, Indicative timetable for evaluation and for signature of the grant agreement
Application

How do you apply?

Pre-registration
Required, before the full application
Required attachments
  • Application form Part A: administrative details of the participants and summary budget (to be completed online)
  • Application form Part B: technical description of the project (PDF, maximum 40 pages)
  • Annex with information on clinical studies (HE template), if the proposal includes clinical studies
Procedure
Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).
Eligible costs

What can the money be spent on?

Personnel costs
Materials
Not eligible
Subcontracting
Equipment
Land
Not eligible
Buildings
Not eligible
Overheads
Travel costs
Other costs
Actual costs in accordance with General Annex G and the Horizon Europe Model Grant Agreement; indirect costs at a flat rate of 25%. Funding rate 100%.
Downloads

Files & forms

Changes

What has changed?

10 November 2026scheme · version 6

Subtitle
Subtitle: ChangedShow
Before

Onderzoek naar klimaatgerelateerde blootstelling binnen het menselijk exposoom.

Now

Research on climate-related exposures within the human exposome.

Description
Description: ChangedShow
Before

Projecten brengen klimaatgerelateerde blootstellingen (zoals hitte, luchtkwaliteit en extreme weersomstandigheden) samen met andere omgevingsfactoren in het exposoomonderzoek en karakteriseren hoe deze blootstellingen en hun gezondheidseffecten veranderen. Doel is beter onderbouwd beleid en betere preventie voor onderzoekers, beleidsmakers, zorgverleners en burgers.

Now

Projects bring climate-related exposures (such as heat, air quality and extreme weather conditions) together with other environmental factors in exposome research and characterise how these exposures and their health effects change. The aim is better-informed policy and better prevention for researchers, policymakers, healthcare providers and citizens.

Short description
Short description: ChangedShow
Before

Horizon Europe-onderzoeksactie (RIA) die klimaatgerelateerde blootstellingen integreert in het menselijk exposoom en in kaart brengt hoe dat exposoom en de gezondheidseffecten veranderen door klimaatverandering.

Now

Horizon Europe research action (RIA) that integrates climate-related exposures into the human exposome and maps how that exposome and the health effects change as a result of climate change.

Cycle
Cycle: ChangedShow
Before

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Now

Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F).

Note on the total budget
Note on the total budget: ChangedShow
Before

Indicatief topicbudget, naar verwachting 4 projecten.

Now

Indicative topic budget, expected to fund 4 projects.

Note on the maximum
Note on the maximum: ChangedShow
Before

Geen bindend maximum; de Commissie acht € 10 mln tot € 11 mln EU-bijdrage per project passend.

Now

No binding maximum; the Commission considers an EU contribution of €10 million to €11 million per project appropriate.

Cumulation
Cumulation: ChangedShow
Before

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Now

No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).

Search engine title
Klimaat en het menselijk exposoom (Horizon HLTH) becomes Climate and the human exposome (Horizon HLTH)
Search engine description
Search engine description: ChangedShow
Before

Horizon Europe-onderzoeksactie (circa € 10-11 mln per project) naar klimaatgerelateerde blootstelling binnen het menselijk exposoom.

Now

Horizon Europe research action (approx. €10-11 million per project) on climate-related exposures within the human exposome.

Keywords
Cluster 1 Health, exposoom, Horizon Europe, HORIZON-HLTH-2027-01-ENVHLTH-02, klimaatverandering en gezondheid, omgevingsfactoren becomes climate change and health, Cluster 1 Health, environmental factors, exposome, Horizon Europe, HORIZON-HLTH-2027-01-ENVHLTH-02
Language
Dutch (Netherlands) becomes British English
Required attachments
Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's); Bijlage met informatie over klinische studies (HE-sjabloon), als het voorstel klinische studies omvat becomes Application form Part A: administrative details of the participants and summary budget (to be completed online); Application form Part B: technical description of the project (PDF, maximum 40 pages); Annex with information on clinical studies (HE template), if the proposal includes clinical studies
Procedure
Procedure: ChangedShow
Before

Aanvragen via het Funding & Tenders Portal met een EU Login en een PIC-nummer; single-stage; deadline 17:00 uur Brusselse tijd; beheerd door European Health and Digital Executive Agency (HaDEA).

Now

Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).

Notes per cost type
Notes per cost type: ChangedShow
Before

Other costs: Werkelijke kosten volgens General Annex G en de Horizon Europe-modelovereenkomst; indirecte kosten forfaitair 25%. Financieringspercentage 100%.

Now

Other costs: Actual costs in accordance with General Annex G and the Horizon Europe Model Grant Agreement; indirect costs at a flat rate of 25%. Funding rate 100%.

Why this scheme
Why this scheme: ChangedShow
Before

Gezondheidsrisico's van klimaatverandering beter begrijpen en voorkomen.

Now

Better understand and prevent the health risks of climate change.

In brief
In brief: ChangedShow
Before

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; onderzoeksinstellingen, bedrijven van elke omvang, overheden, stichtingen en verenigingen kunnen deelnemen. Ook organisaties uit de Verenigde Staten kunnen EU-financiering krijgen; het Joint Research Centre kan na selectie zonder financiering of als geassocieerde partner aansluiten.

What for: Een onderzoeks- en innovatieactie om klimaatgerelateerde blootstellingen in het menselijk exposoom op te nemen en de veranderingen daarvan door klimaatverandering in kaart te brengen, zodat de gezondheidsrisico's van klimaatverandering beter worden begrepen en voorkomen.

What you get: Een subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 10 tot 11 miljoen per project passend. Het indicatieve budget voor het topic is € 45 miljoen, naar verwachting voor 4 projecten.

What you need to do: Dien van 29 oktober 2026 tot uiterlijk 17 februari 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en deel B en, als het voorstel klinische studies omvat, de bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

Now

Who: A consortium of at least three independent organisations from three different countries, of which at least one is from an EU Member State and the others from Member States or Associated Countries; research organisations, companies of any size, public authorities, foundations and associations can take part. Organisations from the United States can also receive EU funding; the Joint Research Centre may join after selection without funding or as an associated partner.

What for: A research and innovation action to include climate-related exposures in the human exposome and to map how it changes as a result of climate change, so that the health risks of climate change are better understood and prevented.

What you get: A grant of 100% of eligible costs; the Commission considers an EU contribution of €10 to 11 million per project appropriate. The indicative budget for the topic is €45 million, expected to fund 4 projects.

What you need to do: Submit a proposal in a single round via the Funding & Tenders Portal from 29 October 2026 until 17 February 2027 (17:00 Brussels time) at the latest, with application form Part A and Part B and, if the proposal includes clinical studies, the annex on clinical studies. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.

Goals
Goals: 3 removed, 3 newShow
Removed

Beter begrip van het exposoom Onderzoekers, beleidsmakers, zorgverleners en het publiek begrijpen het menselijk exposoom en de wisselwerking tussen klimaat-, omgevings- en sociaal-gedragsfactoren beter, ondersteund door FAIR-data die deze blootstellingen aan ziekte en gezondheid koppelen.

Kennis over gezondheidseffecten Onderzoekers, overheden, beleidsmakers, sociale diensten en zorgverleners weten meer over de verbanden tussen klimaat-, sociale, leefstijl- en omgevingsfactoren en de wereldwijde ziektelast, zodat zij de exposoombenadering kunnen toepassen.

Informatie voor het publiek Het publiek heeft toegang tot actuele informatie over de invloed van mondiale omgevingsblootstelling op gezondheid, zodat gezond, klimaatbestendig en natuurvriendelijk gedrag makkelijker wordt.

New

Better understanding of the exposome Researchers, policymakers, healthcare providers and the public better understand the human exposome and the interplay between climate, environmental and socio-behavioural factors, supported by FAIR data linking these exposures to disease and health.

Knowledge of health effects Researchers, public authorities, policymakers, social services and healthcare providers know more about the links between climate, social, lifestyle and environmental factors and the global burden of disease, so that they can apply the exposome approach.

Information for the public The public has access to up-to-date information on the influence of global environmental exposures on health, making healthy, climate-resilient and nature-friendly behaviour easier.

Show 5 earlier versions

29 October 2026scheme · version 5

De call is op 29 oktober 2026 geopend. Voorstellen kunnen tot en met 17 februari 2027 worden ingediend.

Status
Opening soon becomes Open

19 October 2026scheme · version 4

Conditions
Conditions: 2 removed, 6 newShow
Removed

Consortium van minimaal 3 partijen Drie onafhankelijke juridische entiteiten uit drie verschillende EU-lidstaten of geassocieerde landen, waarvan minimaal één uit een lidstaat (General Annex B).

Entiteiten uit de Verenigde Staten subsidiabel Juridische entiteiten gevestigd in de Verenigde Staten kunnen EU-financiering ontvangen, vanwege de openstelling van NIH-programma's voor Europese onderzoekers.

New

To be eligible for funding, applicants must be established in one of the following countries:

Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.

Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

The Joint Research Centre (JRC) may participate as member of the consortium selected for funding as a beneficiary with zero funding, or as an associated partner.

In brief
In brief: AddedShow
Now

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; onderzoeksinstellingen, bedrijven van elke omvang, overheden, stichtingen en verenigingen kunnen deelnemen. Ook organisaties uit de Verenigde Staten kunnen EU-financiering krijgen; het Joint Research Centre kan na selectie zonder financiering of als geassocieerde partner aansluiten.

What for: Een onderzoeks- en innovatieactie om klimaatgerelateerde blootstellingen in het menselijk exposoom op te nemen en de veranderingen daarvan door klimaatverandering in kaart te brengen, zodat de gezondheidsrisico's van klimaatverandering beter worden begrepen en voorkomen.

What you get: Een subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 10 tot 11 miljoen per project passend. Het indicatieve budget voor het topic is € 45 miljoen, naar verwachting voor 4 projecten.

What you need to do: Dien van 29 oktober 2026 tot uiterlijk 17 februari 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en deel B en, als het voorstel klinische studies omvat, de bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

18 October 2026scheme · version 3

About the scheme
About the scheme: AddedShow
Now

The exposome is the totality of exposures (and their interactions) experienced by an individual throughout their lifetime, including chemical, physical, biological, nutritional and psychosocial factors, from conception onwards. Many of these factors originate in the environment, including climate-related exposures such as extreme heat, heightened air pollution or drought. Climate change may amplify or interact synergistically with other better-established exposures, dynamically altering the human exposome and its health implications. Despite this, climate factors remain underrepresented in large-scale human exposome studies.

16 October 2026scheme · version 2

Cycle
Cycle: AddedShow
Now

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Cumulation
Cumulation: AddedShow
Now

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Keywords
Added: Cluster 1 Health, exposoom, Horizon Europe, HORIZON-HLTH-2027-01-ENVHLTH-02, klimaatverandering en gezondheid, omgevingsfactoren
Required attachments
Added: Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's); Bijlage met informatie over klinische studies (HE-sjabloon), als het voorstel klinische studies omvat
Goals
Goals: 3 newShow
New

Beter begrip van het exposoom Onderzoekers, beleidsmakers, zorgverleners en het publiek begrijpen het menselijk exposoom en de wisselwerking tussen klimaat-, omgevings- en sociaal-gedragsfactoren beter, ondersteund door FAIR-data die deze blootstellingen aan ziekte en gezondheid koppelen.

Kennis over gezondheidseffecten Onderzoekers, overheden, beleidsmakers, sociale diensten en zorgverleners weten meer over de verbanden tussen klimaat-, sociale, leefstijl- en omgevingsfactoren en de wereldwijde ziektelast, zodat zij de exposoombenadering kunnen toepassen.

Informatie voor het publiek Het publiek heeft toegang tot actuele informatie over de invloed van mondiale omgevingsblootstelling op gezondheid, zodat gezond, klimaatbestendig en natuurvriendelijk gedrag makkelijker wordt.

7 October 2026scheme · version 1 · first publication

Source

Contact & source

Funding body
European Health and Digital Executive Agency
Last verified
16 November 2026 by the Twin editors
Start your application

Start your HORIZON-HLTH-2027-01-ENVHLTH-02 application
in Twin.

Twin helps you write your application, based on the scheme and your own project documents. You stay in control of every text.